PROCORALAN

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Tunisia, United Kingdom

Active ingredients

The drug PROCORALAN contains one active pharmaceutical ingredient (API):

1 Ivabradine
UNII TP19837BZK - IVABRADINE HYDROCHLORIDE

Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation.

Read about Ivabradine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PROCORALAN Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C01EB17 Ivabradine C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 531302101111218, 531302102118216, 531302103114214, 531302104110212
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00434721, 00434738, 00673087, 01688122, 01689110, 02256778, 03879151, 03879814, 03880556, 03880579, 05389310, 06441403, 06441426, 07577754, 10004795, 10004803, 10004826, 10130850, 10203218, 10321053, 10321076, 10321082, 10402426, 10526051, 10554515, 10554538, 11214170, 11226799, 11258210, 11542595, 12381295, 12389279, 13862513, 15266301, 15619774, 16031681, 16031698, 17368968, 17421421
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.819-11-07, 27.872-10-07
Country: EE Ravimiamet Identifier(s): 1219463, 1219474, 1219485, 1219496, 1219508, 1219519, 1219520, 1219531, 1219542, 1219553, 1219564, 1219575, 1219586, 1219597
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 05316003, 05316003IP, 05316003IP1, 05316010, 05316010IP, 05316010IP1, 05316010IP2
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 041086, 041096, 041105, 041114
Country: FR Base de données publique des médicaments Identifier(s): 61952527, 63501124
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 375319, 381637, 381639, 98303, 98306
Country: IE Health Products Regulatory Authority Identifier(s): 42703, 42704, 42706, 42710, 42720, 42721, 42725, 42774
Country: IT Agenzia del Farmaco Identifier(s): 037061013, 037061025, 037061037, 037061049, 037061052, 037061064, 037061076, 037061088, 037061090, 037061102, 037061114, 037061126, 037061138, 037061140
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030448, 1030449, 1030450, 1030451, 1030452, 1030453, 1030454, 1030455, 1030456, 1030457, 1030458, 1030459, 1030460, 1030461
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 204M2007
Country: NL Z-Index G-Standaard, PRK Identifier(s): 198161, 198188
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100147059, 100147065
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6353171, 6353172

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.